Are you Telling the Right Story in your MedTech Investor Pitch Deck?
Join NAMSA for a dynamic one-hour session designed specifically for MedTech startups navigating the financing rounds landscape. This webinar brings together the dual perspectives of a seasoned Venture Capitalist and a Regulatory and Clinical expert (ex-FDA) to unpack what truly resonates in a pitch deck. From due diligence expectations to regulatory, reimbursement, and clinical evidence essentials, you’ll gain actionable insights to elevate your investor presentations. Whether you’re refining your first deck or preparing for your next funding round, this session will help you stand out in a crowded field.
Key Learning Objectives:
- Understand investor expectations during due diligence and how to align your pitch accordingly
- Learn what regulatory, reimbursement, and clinical evidence should be included in your deck – and why it matters
- Explore real-world examples of effective (and ineffective) pitch decks from experienced investors and Regulatory and Clinical experts
- Gain practical tips on storytelling, market positioning, and avoiding common pitfalls in early-stage fundraising
Speakers
Chief Medical Officer at NAMSA
As a Board-Certified Cardiothoracic Surgeon, Dr. Saltman has more than 25 years’ experience in the management of complex patients with multiple comorbidities. He also worked for 12 years as a Medical Officer at the U.S. FDA Center for Devices and Radiological Health, where he gained a deep understanding of the requirements for successful medical device introductions, as well as quality systems, compliance and benefit-risk evaluations. Before joining NAMSA, Dr. Saltman earned industry experience as the first Chief Medical and Regulatory Officer for two medical device organizations, during which he successfully brought three AI-powered devices through R&D, clinical validation, regulatory approval and market introduction.
Ivanny Franklin
Global Clinical Strategy Director at NAMSA
Ivanny Franklin brings a rare dual perspective to the MedTech investment landscape, combining deep clinical strategy expertise with hands-on venture capital experience. As Global Clinical Strategy Director at NAMSA and Managing Partner at MedSight Capital, she specializes in guiding startups through the complexities of clinical evidence generation, regulatory strategy, and reimbursement pathways. Her background in managing a family office further sharpens her insight into what investors seek in a compelling pitch. Ivanny’s strategic approach helps early-stage companies align their value proposition with investor expectations, making her a vital voice in this session.
Owen Willis
Founder at Opal Ventures
Owen Willis is the founder and General Partner of Opal Ventures where he backs founders building the next generation of healthcare infrastructure. He was previously COO of Osmosis (acquired by Elsevier), where he ran B2B go-to-market and built the On Deck Health community for ideation and pre-seed stage health tech founders.
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.
NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.
This is a free educational webinar.
